Category: ACN Newswire

HONG KONG, July 22, 2025 - (ACN Newswire via SeaPRwire.com) - On July 22, CaoCao announced a strategic partnership with Geespace, a leading commercial aerospace company in China, to further enhance autonomous driving safety standards by leveraging the satellite services of the "Geely Constellation." The collaboration aims to ensure that robotaxis remain "always online, never disconnected."(Attendees: Yang Jian, Vice Chairman of Zhejiang Geely Holding Group (third from left); Gong Xin, Executive Director and CEO of CaoCao (second from left); Wang Yang, CEO of Geespace (second from right); Qiang Qi, CTO of CaoCao (first from left); Qu Suchao, Deputy General Manager of Geespace and General Manager of Lane Position (first from right))Both parties plan to explore the application of global satellite communication and high-precision positioning technologies for managing and operating robotaxi fleets. The integration of satellite application products and services into CaoCao's robotaxis will establish CaoCao as the world’s first mobility platform to fully incorporate low-Earth orbit (LEO) satellite communication and centimeter-level, high-precision positioning technologies into robotaxi operations. This initiative paves the way for the future large-scale deployment of robotaxis and ensures their safety.Satellite Direct-to-Device Enhances Vehicle Safety RedundancyWhen it comes to safety, CaoCao's human-driven ride-hailing service is already ahead of the industry. CaoCao's accident rate per order in both 2023 and 2024 was significantly lower than the industry average, according to Frost & Sullivan data. This was due to the company's hardware redundancy and professional drivers.Currently, CaoCao is conducting a pilot program for robotaxis and steadily expanding its fleet. To provide the safest possible travel experience for robotaxis, CaoCao is leveraging aerospace technology to improve safety beyond vehicle hardware redundancy. These lay a solid foundation for the upcoming rapid development phase of autonomous driving.It is learned that robotaxis on the CaoCao platform will gain two key capabilities:Safety Redundancy of Satellite Communication: Robotaxis are equipped with integrated satellite communication capabilities to ensure real-time data transmission and emergency status reporting even in remote operational areas. As a result, uninterrupted and dependable connectivity between robotaxis and the control center establishes a substantial foundation for remote monitoring, dispatching, and emergency intervention.Centimeter-Level Positioning Accuracy: Robotaxis are paired with high-precision sensors. These sensors minimize positioning errors to an extremely low level. They can even achieve precise lane-level positioning and tracking in complex environments like urban canyons and overpasses. Additionally, their strong ability to withstand interference ensures that positioning signals remain stable and reliable during severe weather, including heavy rain.Gong Xin, CEO of CaoCao, stated: “Safety is the core prerequisite and ultimate test for robotaxi commercialization. By selecting and deploying satellite application products and services, we are integrating 'heaven' (satellite technology) and 'earth' (robotaxi intelligence) to build an innovative, multilayered safety redundancy system. This system represents not only a synergy of cutting-edge technologies, but also CaoCao's firm commitment to safeguarding user safety and leading the future of secure mobility."Further Upgraded Robotaxi Ecosystem of CaoCaoBacked by the Geely Group, CaoCao is a key pillar of the group’s future mobility strategy, establishing China’s first closed-loop, fully self-developed ecosystem encompassing "customized vehicles + autonomous driving technology + mobility platform." CaoCao now stands as the only Chinese mobility company whose full-chain capabilities are comparable to Tesla’s "manufacturing + autonomous driving + operations" model.CaoCao’s robotaxi platform seamlessly integrates its operational expertise with the Geely Group’s strengths in automotive manufacturing and autonomous driving technology. With its proven capabilities in service standardization, cost optimization, and asset management—all validated through customized vehicles—CaoCao is well-positioned to drive the large-scale deployment of robotaxi services.The strategic partnership with Geespace exemplifies the efficient synergy within the Geely Group’s smart mobility technology ecosystem. As the Geely Group’s provider of aerospace information and communication infrastructure and solutions, Geespace focuses on constructing and operating a LEO satellite constellation, manufacturing satellites, and developing satellite applications. Geespace also independently builds and operates the "Geely Constellation," which currently consists of 30 in-orbit satellites and over 5,000 high-precision ground-based positioning stations across China. These efforts rank Geespace among the industry leaders in terms of hardware scale and operational support capabilities.As members of the Geely ecosystem, CaoCao and Geespace collaborate to eliminate data coordination barriers caused by differing technical standards in traditional supply chains. This not only highlights the synergistic advantages of CaoCao’s robotaxi ecosystem but also propels China’s autonomous driving industry into a new phase of secure and controllable ecological integration, moving beyond mere technological convergence. Copyright 2025 ACN Newswire via SeaPRwire.com.

The Calculator helps Malaysian companies identify key GHG emission sources in line with the ‘Emissions’ disclosure requirements of the Simplified ESG Disclosure Guide (SEDG) for SMEs in Supply Chains.KUALA LUMPUR, July 22, 2025 - (ACN Newswire via SeaPRwire.com) - Capital Markets Malaysia (“CMM”), an affiliate of the Securities Commission Malaysia (“SC”), today launched the SEDG Greenhouse Gas (“GHG”) Emissions Calculator for Small and Medium Enterprise (“SMEs”). The user-friendly tool is designed to help Malaysian companies measure and report their Scope 1 and Scope 2 emissions based on the globally recognised Greenhouse Gas (GHG) Protocol.Dato’ Mohammad Faiz Azmi, Executive Chairman of the SC and Chairman of CMM said, “For many SMEs in Malaysia, particularly those operating in global supply chains, the ability to accurately measure and report their Scope 1 and Scope 2 emissions is critical in responding to disclosure demands of their customers.Photo 1: Dato' Mohammad Faiz Azmi, Executive Chairman of the SC and Chairman of CMM“The SEDG GHG Emissions Calculator simplifies a complex process, making emissions reporting accessible even to first-time users. Beyond reporting, it also enables companies to pinpoint key emission sources across operations, allowing them to make informed decisions and move towards meaningful climate action,” he said.“The calculator further complements efforts by the SC to promote consistent and credible sustainability disclosures and supports the adoption of the National Sustainability Reporting Framework by Malaysian companies,” he added.To ensure consistency and credibility, the SEDG GHG Emissions Calculator utilises a methodology which follows widely accepted international standards such as the GHG Protocol Corporate Accounting and Reporting Standard and Intergovernmental Panel on Climate Change (IPCC). These standards are also used by the Malaysian government in the Biennial National Communications to the UNFCCC.The Calculator comes with pre-filled emission factors from the IPCC'S 6th Annual Report (AR6) for fuel combustion commonly used in Malaysia such as diesel, petrol, LPG, natural gas, and others. Emission factors for grid electricity consumption come from local sources such as publications from Malaysia’s Energy Commission.Navina Balasingam, General Manager of CMM said, “The SEDG has received widespread acceptance since its launch in October 2023. We’ve seen a strong response from Malaysian and multinational companies with large supply chains, utilising the SEDG to support ESG reporting by their SME suppliers.Photo 2: Navina Balasingam, General Manager of CMM“CMM will continue its nationwide workshops to help SMEs in supply chains disclose ESG data credibly and effectively. The Calculator is a key part of this effort, further simplifying the ‘Emissions’ disclosure requirements of the SEDG,” she said.“In developing the tool, we carried out a series of user acceptance tests (UATs) to understand the needs and expectations of SMEs across diverse sectors within the supply chain. To ensure broad accessibility, the Calculator is available at no cost to users, in three languages – English, Bahasa Melayu and Simplified Mandarin,” she added.As global sustainability standards, customer expectations, and ESG compliance requirements continue to evolve, it is essential that the SEDG remains relevant and practical for Malaysian businesses. In line with this, CMM also announced the release of SEDG Version 2, which includes three additional recommended disclosures designed to better align with the reporting needs of global customers.For more information, visit https://sedg.capitalmarketsmalaysia.com/About Capital Markets Malaysia (CMM)The Securities Commission Malaysia (SC) set up CMM in 2014 to spearhead the local and international positioning as well as profiling of the Malaysian capital market. Funded by the Capital Markets Development Fund, CMM showcases the competitiveness and attractiveness of the various segments of the Malaysian capital market – to promote international participation and enhance opportunities for domestic capital market intermediaries. CMM works to support the advancement of these entities through various initiatives and partnerships, focusing on four key areas: sustainable finance and investing, the Islamic capital market, the digital market, and capital market funding opportunities through the private market.For media queries, please contact:Farina FaridHead of Communications, Capital Markets MalaysiaE: FarinaF@seccom.com.my Copyright 2025 ACN Newswire via SeaPRwire.com.

香港，2025年7月22日 - (亞太商訊 via SeaPRwire.com) - 曹操出行宣佈與國內領先的商業航天公司時空道宇達成戰略合作，將依託「吉利星座」的衛星服務，進一步提升自動駕駛安全標準，致力於實現服務車輛「永遠線上，永不失聯」。（出席人員：吉利控股集團董事局副主席楊健（左三），曹操出行執行董事兼CEO龔昕（左二），時空道宇CEO王洋（右二），曹操出行首席技術官強琦（左一），時空道宇副總經理、漣漪位置總經理曲蘇超（右一））雙方計畫共同探索將全球衛星通信與高精定位技術應用於自動駕駛車隊的管理與運營，曹操智行自動駕駛平台的運營車輛將標配相關衛星應用產品及服務。此舉標誌著曹操智行將成為全球首個在Robotaxi運營中全面整合低軌衛星通信與釐米級高精定位技術的出行平台，為未來Robotaxi規模化運營奠定安全基礎。衛星直連提升車輛安全冗餘在安全方面，曹操出行的有人駕駛網約車服務已處於行業領先地位。弗若斯特沙利文資料顯示，憑藉硬體冗余和專業司機保障，曹操出行在2023年及2024年的訂單事故率均顯著低於行業平均水準。當前，曹操出行正積極開展自動駕駛服務示範運營，並穩步擴大車隊規模。為追求Robotaxi的極致安全出行體驗，在車輛硬體安全冗餘的基礎上，曹操出行以航天科技賦能出行安全，為自動駕駛高速發展階段的到來奠定堅實基礎。據悉，曹操智行平台車輛將獲得兩大關鍵能力：衛星通信安全冗餘：車輛集成衛星通信能力，確保在運營區域（包括偏遠地區）都能保持即時資料傳輸和緊急狀態上報。這保證了車輛與控制中心之間持續可靠的連接，為遠端監控、調度和緊急干預提供了堅實保障。釐米級定位精度：配合高精度的感測器，車輛定位誤差可被控制在極低水準，即使在城市峽谷、立交橋等複雜區域，也能實現精准的車道級定位與追蹤。同時，強大的抗干擾能力確保車輛在暴雨等惡劣天氣下定位信號依然穩定可靠。曹操出行CEO龔昕表示：「安全是自動駕駛商業化的核心前提和終極考驗。我們選擇並部署衛星應用產品及服務，通過『天』（衛星技術）『地』（車輛智能）一體技術整合，正在構建一個創新的多重安全冗餘體系。這不僅是前沿技術的協同，更是曹操出行全力保障用戶安全利益、引領未來安全出行方式的堅定決心。」曹操智行Robotaxi生態再升級曹操出行是吉利集團未來出行戰略佈局的重要落腳點，背靠吉利集團，曹操出行已構建起國內首個「定制車+自動駕駛技術+出行平台」全域自研閉環生態，成為國內唯一具備類似特斯拉「製造+智駕+運營」全鏈條能力的出行公司。曹操智行自動駕駛平台無縫整合了曹操的運營經驗與吉利集團的汽車製造、自動駕駛技術優勢，曹操出行基於定制車已驗證的服務標準化能力、成本優化路徑和成熟的資產管理體系，將有力推動Robotaxi服務的規模化落地。此次與時空道宇的戰略合作，也是吉利智能出行科技生態高效協同的生動體現。時空道宇作為吉利旗下航天資訊與通信基礎設施和應用方案提供商，聚焦低軌衛星星座建設及運營，衛星製造及衛星應用領域。其自主建設及運營「吉利星座」，目前已有30顆在軌衛星，同時已在國內佈局5000余個高精定位地基資料網站，硬體設施規模、運維保障能力均居國內領先水準。同為吉利生態企業，曹操出行與時空道宇的合作技術上能夠有效解決傳統供應鏈中因技術標準差異導致的資料協同壁壘。這不僅彰顯了曹操出行Robotaxi生態的協同優勢，也推動中國自動駕駛產業從技術整合邁向安全可控的生態融合新階段。 Copyright 2025 亞太商訊 via SeaPRwire.com.

BANGKOK, July 21, 2025 - (ACN Newswire via SeaPRwire.com) - Spacely AI, the Bangkok-based startup bringing generative AI to architecture and interior design, has raised US $1 million in Seed funding led by PropTech Farm Fund III, with participation from Wannaporn Phornprapha (Managing Director, P Landscape Co., Ltd.), Ted Poshakrishna Thirapatana (Founder, UTC Holdings Co., Ltd.), and Mek Srunyu Stittri (former VP Engineering, GitLab). The round follows Spacely AI's pre-seed investment from SCB 10X. The new capital will accelerate product development and expand the company's footprint in key global markets.Spacely AI Seed Round Fundraising InfographicSpacely AI's mission is to help architects win more business, unlock greater creativity, and cut costs. Its cloud suite delivers AI rendering for interior and exterior spaces, intuitive image-editing tools, AI virtual staging, and automated 3D model generation. Fully integrated with SketchUp via Extension Warehouse, the platform is adding support for more leading CAD tools so professionals can work inside the software they already know."Every architecture firm is rebuilding its workflow around AI," said Paruey Anadirekkul, CEO of Spacely AI. "Success now depends on how quickly you adapt - especially as clients are already experimenting with these tools."Seed proceeds will launch Spacely AI's next-generation 2D-to-3D automation engine, which removes up to 80 percent of manual concept work, establish a U.S. market presence, and equip global partners with sales and co-marketing resources."Design speed now determines deal speed," noted Fredrik Bergman, CEO of PropTech Farm. "We at PropTech Farm believe Spacely AI's instant visualisation turns hesitant prospects into committed buyers long before the first brick is laid."Wannaporn Phornprapha, Managing Director of P Landscape Co., Ltd., added, "Design workflows can be painfully slow. Spacely AI shows how technology can save time and energy for the work that truly matters."Over the past year, Spacely AI has grown revenue 10×, served more than 1,500+ architecture and interior-design firms in 50+ countries, and produced over two million unique renders. The company has won 1st Place at the Krungsri Finno Efra Accelerator, People's Choice at Paddle AI Launchpad, 2nd Runner-Up at the SketchUp Innovation Challenge, 1st Place at the Property Portal Watch Conference, a Top-10 spot in Echelon Top 100 Southeast Asia, and 2nd Runner-Up at Tech in Asia Startup Arena. The Verge recently named Spacely AI one of the most-recommended AI tools for design professionals.Spacely AI invites architects, interior designers, and real estate professionals to integrate AI into their workflows and experience a new standard of speed and creativity. Start a free trial or book a live demo at spacely.ai. Together, Spacely AI and its members will eliminate bottlenecks, spark bold ideas, and win projects faster.About Spacely AISpacely AI is a SaaS company bringing generative AI to the Architecture, Engineering, and Construction industry. Spacely AI's mission is to empower design professionals to win more business, unleash greater creativity, and cut project costs.About PropTech FarmPropTech Farm is a venture capital firm investing in early-stage real estate technology companies across Asia-Pacific and Europe. Backed by an experienced team with a track record of successful exits, the firm focuses on startups transforming the built environment across the full lifecycle-from planning and construction to property management and energy optimization. PropTech Farm combines hands-on support with global networks to help founders scale innovative solutions in complex, high-growth markets.PropTech Farm Fund 3 is structured as a sub-fund of Florissant VCC and managed by Swiss-Asia Financial Services.Contact InformationNawinda HanMarketinghello@spacely.aiSOURCE: Spacely AI Copyright 2025 ACN Newswire via SeaPRwire.com.

SINGAPORE, July 21, 2025 - (ACN Newswire via SeaPRwire.com) - On July 15 2025, to mark the successful secondary listing of China Medical System Holdings Limited ("CMS" or the "Group") on the Main Board of the Singapore Exchange ("SGX"), SGX and CMS co-hosted the "Singapore and Emerging Markets Pharmaceutical Industry Growth Forum & CMS SGX Secondary Listing Appreciation Dinner". Held in a grand fashion, the event was held at the Group's CDMO manufacturing facility, PharmaGend, which is located in Tuas, Singapore.The event brought together about 150 representatives from local government agencies, multinational pharmaceutical companies, innovative biotech companies, leading investment institutions, and the KOLs in the pharmaceutical industry. Through a series of insightful keynote speeches and panel discussions, guests engaged in in-depth exchanges and shared ideas on various topics, such as the pharmaceutical industry's development in Singapore and emerging markets across the Asia-Pacific region, the breakthroughs and overseas expansion of Chinese innovative drugs, the globalization strategies, commercialization pathways, as well as ecosystem collaboration of innovative pharmaceutical companies.The forum began with opening remarks by Ms. Caihan Chia, Head of Greater China Capital Markets and Chief Representative of Beijing Representative Office at SGX, and Ms. Louise Ho, Assistant Vice President of Healthcare Division and China Desk at the Singapore Economic Development Board. These were followed by keynote addresses from Mr. Siang Sheng Foo, Head of Investment Banking at Singapore CGS International Securities, Mr. Shriharsha Sarkar, Partner for Asia Healthcare at L.E.K. Consulting, and Ms. Kah Yean Neo, Senior Director at Singapore's Agency for Science, Technology and Research (A*STAR).Ms. Caihan Chia stated that in recent years, SGX has become increasingly attractive to Chinese enterprises through policy refinements, including tax incentives, capital support from the secondary market, and streamlined regulatory procedures. The successful listing of CMS showcases the growing interest among Chinese companies in the Singapore market. As one of leading healthcare companies, CMS's listing highlights the growing demand for medical innovation and medical service accessibility across Asia. With CMS seeking to expand its business in Southeast Asia, its listing on SGX will serve as a strategic springboard to connect with international investors and further reinforce Singapore's role as a vital capital hub.Emerging Markets: A New Growth Engine for the Global Pharmaceutical IndustryEmerging markets, such as Southeast Asia and the Middle East, are becoming new growth drivers for the global pharmaceutical industry. A combination of factors, including large populations, early signs of ageing, the rise of the middle class, growing health awareness, and the increasing burden of chronic diseases, is driving higher demand for medicines and improved accessibility. According to IQVIA, by 2028, the combined pharmaceutical market size of four major emerging regions - Asia-Pacific, India, Africa & the Middle East, and Latin America - is expected to reach USD 336 - 384 billion, comparable to the USD 410 billion market size projected for Western Europe.Singapore possesses geographical and institutional advantages for accessing Southeast Asia, the Middle East, and other emerging markets. With its robust financial system, open and inclusive policy environment, and thriving pharmaceutical industry, Singapore is increasingly becoming a global hub for capital and innovation. It has also become the preferred location for regional headquarters for many Chinese enterprises expanding into Southeast Asia.Seizing Opportunity: Strategic Pathways for Chinese Innovative Pharma to Expand into Emerging MarketsIn Southeast Asia's six major economies (SEA6), limited healthcare coverage means that out-of-pocket payments constitute the primary source of drug expenditure. While generics dominate, branded originator drugs continue to hold significant market share in private hospitals, retail pharmacies, and clinics. Patient demand for biologics and biosimilars continues to grow.In terms of commercialization models, traditional distribution model, which relies on third-party logistics (3PL), is gradually giving way to models with stronger commercial capabilities and strategic licensing partnerships. To achieve sustainable success in Southeast Asia, pharmaceutical companies must build competitive product portfolios, leverage experienced local sales teams, and consider establishing localized manufacturing capabilities, widely seen as key strategic advantages.The CMS's Approach: Building Dual Hubs in China and Singapore to Drive End-to-End InnovationWith over 30 years of experience in the Chinese market, CMS has accumulated a differentiated product portfolio and mature commercialization capabilities. Today, the Group is expanding its strategic vision across the Asia-Pacific region, using China as a foundation and Singapore as its regional hub. Through an end-to-end value chain of "R&D–manufacturing–commercialization–investment", CMS is driving innovation to deliver high-quality pharmaceutical products and services to patients worldwide.Mr. Lam Kong, Chairman, Chief Executive and President of CMS, delivered a keynote speech titled "New CMS, New Ascent: Three Strategies to Drive the Second Growth Curve." He shared that since launching its "New CMS" transformation strategy in 2018, the Group has propelled growth through three engines — product innovation, commercial transformation, and international expansion. This has enabled the Group's transition from "China's largest CSO" to "a pharmaceutical company in transformation," and finally, to "an end-to-end innovative pharmaceutical enterprise", with a sustainable second growth curve.In product innovation, driven by a three-dimensional approach of "Licensing, Strategic partnerships, and in-house R&D”, the Group has built a pipeline of nearly 40 FIC/BIC innovative drugs, five of which have been approved in China and are in large-scale clinical use. In the area of commercialization, CMS remains focused on cardio-cerebrovascular, gastroenterology, ophthalmology, and skin health specialties, while enhancing anti-cyclical resilience through a diversified ecosystem of "New retail, E-commerce, and Consumer healthcare". Its skin health subsidiary, Dermavon, has become a niche market leader in China and is now progressing toward a spin-off for an independent listing on the Hong Kong Stock Exchange. In the area of globalization, CMS is creating a dual-track model centred in China and Singapore, using a strategy of "bringing in" to accelerate overseas product launches in China, and a strategy of "moving outward" to establish an end-to-end presence in emerging markets. The successful listing on SGX will enhance its regional synergy and close the loop in the "R&D – Manufacturing – Commercialization – Investment" global value chain, unlocking growth from emerging markets and creating a multi-regional growth framework.CMS formally launched its industrial globalization strategy in 2022. At this event, CMS's international business clusters made their debut, showcasing its forward-looking, full industry chain layout and leadership in setting a new paradigm for Chinese pharmaceutical companies expanding overseas.PharmaGendEstablished in 2023, PharmaGend aims to become Southeast Asia's largest and most reliable CMO/CDMO. It has a site spanning 30,000 square meters and is capable of manufacturing dosage forms such as tablets and capsules, which has been certified by the FDA and HSA, demonstrating its high-standard pharmaceutical manufacturing capabilities for global export. It has future plans to expand production lines for injections, ointments, and nasal sprays. RxilientEstablished in 2021, Rxilient operates by a professional and experienced localized team, and has fully established BD, registration, marketing, andcommercialization capabilities. Leveraging its unique local expertise and advantages, Rxilient can bring innovative drugs to emerging markets led by Southeast Asia and the Middle East. It has submitted marketing applications for nearly 20 drugs and medical devices across Southeast Asia, the Middle East, and regions such as Hong Kong, Macao, and Taiwan, covering the therapeutic areas of dermatology, ophthalmology, oncology, autoimmune, and central nervous system. As more drugs receive regulatory approval in these countries, Rxilient anticipates sustained and significant revenue growth.CMS R&DEstablished in Singapore in 2024, CMS R&D has been working on more than 10 early-stage innovative drug projects. Leveraging China's mature early-stage R&D and clinical resources, it aims to synchronize China speed with global standards to advance more Chinese innovative drugs toward globalization.HiGendEstablished in 2025, HiGend is a global early-stage bio-pharma incubation platform which uses a "hub-and-spoke" model, integrating China's innovation capabilities to accelerate global R&D and commercialization.Subsequently, three panel discussions were held in succession, which facilitated an in-depth exchange between industry and capital, driving the forum to its climax. Distinguished guests from various parties freely shared insights on the continuous development and diversification of the pharmaceutical ecosystem, and jointly explored the future of pharmaceutical expansion into emerging markets.Panel Discussion 1 – Challenges and Breakthroughs: The Enduring Power of Organizational and Strategic Long-Term VisionThe emerging markets of today share numerous similarities with China's pharmaceutical landscape twenty years ago, which are currently experiencing a critical period of accelerated demand release for pharmaceuticals, constituting medium- to long-term structural opportunities. Undoubtedly, these markets are diverse and complex — each country has its own unique characteristics in terms of drug regulation, healthcare insurance mechanisms, and market acceptance. However, CMS's core strength lies in its systematic commercialization capabilities, which it is now extending to emerging markets. CMS's senior management team, alongside its business partners, jointly reviewed and discussed the key factors contributing to its commercial excellence, as well as the pathways driving the Group's second growth curve.The first panel discussion was moderated by Mr. Brian Yang, Vice President for Business Development at Rxilient. Participants included Mr. Karl Luschmann, Managing Director of Pharma Stulln GmbH, and Ms. Linlang Wang (formerly the first product manager of the Augentropfen Stulln Mono Eye Drops ("Stulln") in China), General Manager of CMS's ophthalmology business, CMS Vision, among others. Collectively, they reviewed the core strategies behind the rapid, year-on-year growth of Stulln in the Chinese market- a focus on clinical value and continuous innovation in commercialization models. CMS adhered to prioritizing clinical efficacy, amassing substantial evidence to demonstrate the clinical value of Stulln in treating asthenopia, and leveraging medical advancements to drive product commercialization. Meanwhile, CMS also continuously revamped its commercialization model by establishing a full-channel retail system that integrates in-hospital and out-of-hospital sales, developing an "online + offline" omnichannel marketing system, and adopting a diversified product portfolio strategy in consumer attributes. These concerted efforts facilitated the sustained, rapid growth and wide recognition of Stulln within the Chinese market.Mr. Victor Yin, Country Manager of Incyte Bioscience China, Mr. Huang Anjun, CEO of Dermavon (CMS's skin health business), and Mr. Lawrence He, CEO of Rxilient, jointly retraced the entire journey of launching ruxolitinib cream — a blockbuster prescription drug with consumer attributes. From the signing of the collaboration agreement and pilot launch in Hainan Boao Lecheng pilot zone, to marketing approvals in Macao, followed by Hong Kong, introduction into designated hospitals in the Greater Bay Area in China, and the NDA has been submitted in China, Singapore, and other countries or regions. Leveraging mature clinical development experience and capabilities, proven commercialization competence, a compliant operational system, and efficient execution, the group earned high recognition and trust from Mr. Victor Yin.Together, the parties have helped bring new hope to vitiligo patients in both China and Southeast Asia simultaneously.These successful commercialization experiences not only provide valuable business model references for international pharmaceutical companies entering the Chinese market, but also offer significant insights for Chinese pharmaceutical companies looking to expand into emerging markets overseas.Panel Discussion 2 – Breaking Through: Diverse Explorations for Chinese Innovative Pharmaceutical Companies to Expand into Emerging MarketsOver the past three years, Chinese pharmaceutical companies have secured over USD 10 billion in upfront payments through license-out deals. However, the majority of these transactions remain concentrated in mature markets led by Europe and the United States. Looking ahead, the next engine of growth may shift toward emerging markets such as Southeast Asia, the Middle East, and Latin America — regions with a combined population of approximately 1.8 billion and per capita healthcare spending is merely one-fifth that of Western markets. While pharmaceutical demand is accelerating in these areas, challenges persist, including limited payment capacity and significant differences in regulatory systems. Whether Chinese pharmaceutical companies can effectively replicate and localize their domestic development and innovation models in these blue ocean markets, will determine the scale and sustainability of their second growth curve.The second panel discussion, moderated by Mr. Brian Yang, featured esteemed representatives from leading Chinese innovative pharmaceutical companies that are closely collaborating with CMS, including Tibet Nordicon Pharma, NeuroDawn Pharmaceutical (Ningdan Pharmaceutical), Mabgeek Biotech, and Jingze BioPharmaceutical. Using examples such as XinHuoSu (for acute decompensated heart failure), Y-3 for Injection (under development for stroke treatment), ABP-671 (under development for gout) etc., participants held in-depth discussions on topics, including "What constitutes truly clinically valuable innovation" and "How to implement commercialization pathways within emerging markets"True innovation value stems from professionalism and dedicated focus. It requires researchers to remain committed to a specific field over the long term, and to validate new targets and drug structures through reverse translational research, thereby identifying their potential clinical value. Since China officially joined the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) in 2017 and became a member of its steering committee, the quality of Chinese innovative pharmaceutical products has improved rapidly and has gradually gained global recognition. In addition to entering mature markets led by Europe and the U.S., Chinese innovators are increasingly turning their attention to emerging blue ocean markets such as Southeast Asia, actively exploring parallel regulatory filings in both emerging and mature markets. For innovative pharmaceutical companies, globalization strategies should be integrated into the early stages of pipeline development cycles and macro-level strategy. It is also crucial to seek out a business partner that possesses the entire value-chain capabilities — including experienced local clinical registration teams, manufacturing capacity, and commercialization operations—in order to drive efficient product launches and expand access to high-quality medical solutions across a broader range of geographies.Panel Discussion 3 – Setting Sail: Pharmaceutical Expansion into Emerging MarketsThe third panel discussion was moderated by Mr. Frank Hong, Managing Director of Legend Capital, engaging multiple leading pharmaceutical analysts from renowned investment banks and representatives from investment institutions in an insightful sharing and in-depth discussion on the international expansion of innovative drug products and pharmaceutical industry globalization. Participants pointed out that China's pharmaceutical industry is currently at a strategic inflection point for global expansion. The Intellectual Property (IP) licensing model has preliminarily demonstrated the global competitiveness of Chinese innovation. However, for most domestic pharmaceutical companies, this process remains in the "isolatedbreakthrough" phase. To achieve the transition from a practice of "one-time licensing" to "sustained global engagement," Chinese pharmaceutical companies must look to multinational pharmaceutical giants as a benchmark — internationalizing their commercialization, manufacturing, and R&D capabilities to build a replicable, scalable, and sustainable global industrial ecosystem.Achieving this goal is no easy task. While many Chinese pharmaceutical companies have begun exploring emerging markets, they often face challenges such as fragmented distribution channels and difficulty in standardizing operational systems. Only by maintaining conviction and building a fully integrated, internationalized ecosystem across the entire value chain can companies transform one-off licensing revenues into long-term brand equity and control of the value chain, ultimately earning a sustained voice and competitive edge in the global arena.Though the forum's spotlight has dimmed, the consensus reached continues to shine like a beacon: Southeast Asia, the Middle East, and other emerging markets are quickly becoming the next major destinations for the global pharmaceutical industry. CMS's fully localized framework covering "Research, Manufacturing, Commercialization, and Investment" has paved the way for industrial expansion overseas, constructing a bridge to globalization. With an open and win-win attitude, the Group welcomes innovators, regulators, and capital from around the world to work together in bringing more Chinese and global innovative drugs to emerging markets, fostering international growth. CMS sincerely invites partners across all sectors to seize the growth opportunities of the Asia-Pacific region and jointly promote innovation in the pharmaceutical industry across emerging markets, so that more innovative therapies may benefit patients around the world.Media Contact:Company: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/Source: China Medical System Holdings Ltd. Copyright 2025 ACN Newswire via SeaPRwire.com.

Brisbane, Queensland, Australia--(ACN Newswire via SeaPRwire.com - July 21, 2025) - Graphene Manufacturing Group Limited (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to provide an update to the composition of the Company's Technical Advisory Committee which will support the Company as it proceeds into its next phase of development.The Company is pleased to announce the addition of Professor Emeritus Doug Hargreaves AM (Australia) to the Company's Technical Advisory Committee, adding deep insight, experience and connections to GMG.Professor Emeritus Doug Hargreaves AMTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/259441_b86d67f984d8eb7f_001full.jpgDoug is a highly respected Professor Emeritus of Engineering at Queensland University of Technology (QUT), a member of the Order of Australia, previous National President and an Honorary Fellow of the Engineers Australia, Board Member of the Federation of Engineering Institutions in the Asia Pacific and the Executive Officer of the Australian Council of Engineering Deans. Doug has a Doctor of Philosophy (PhD) and a Masters of Science (MSc) with Distinction in Tribology from the University of Leeds. He serves on multiple Committees and Technical Advisory Boards.Doug joins Bob Gaylen (USA), Company Director and the other member of the Technical Advisory Committee.Bob is a highly experienced executive in the battery energy storage world and science/engineering-based communities. Bob was previously the Chief Technology Officer (CTO) of Contemporary Amperex Technology Company Limited (CATL). CATL is widely known as the largest lithium ion battery manufacturer in the world — supplying electric vehicles and high efficiency storage systems. He serves on multiple Committees of Directors and Technical Advisory Boards.GMG's Managing Director and CEO, Craig Nicol, commented: "We welcome Doug to the global GMG team and we look forward to his valuable insights and working with him as we bring GMG's novel product portfolio to various industries around the world."GMG's Director, Bob Galyen, commented: "Welcome Doug — I look forward to your valuable contribution to the Technical Advisory Committee and help supporting the commercialisation of GMG's world leading products."About GMG:GMG is an Australian based clean-technology company which develops, makes and sells energy saving and energy storage solutions, enabled by graphene manufactured via in house production process. GMG uses its own proprietary production process to decompose natural gas (i.e. methane) into its natural elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low cost, scalable, 'tuneable' and low/no contaminant graphene suitable for use in clean-technology and other applications.The Company's present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has initially focused on graphene enhanced heating, ventilation and air conditioning ("HVAC-R") coating (or energy-saving coating) which is now being marketed into other applications including electronic heat sinks, industrial process plants and data centres. Another product GMG has developed is the graphene lubricant additive focused on saving liquid fuels initially for diesel engines.In the energy storage segment, GMG and the University of Queensland are working collaboratively with financial support from the Australian Government to progress R&D and commercialization of graphene aluminium-ion batteries ("G+AI Batteries"). GMG has also developed a graphene additive slurry that is aimed to improve the performance of lithium-ion batteries.GMG's 4 critical business objectives are:Produce Graphene and improve/scale production processesBuild Revenue from Energy Savings ProductsDevelop Next-Generation BatteryDevelop Supply Chain, Partners & Project Execution CapabilityFor further information please contact:Craig Nicol, Chief Executive Officer & Managing Director of the Company at craig.nicol@graphenemg.com, +61 415 445 223Leo Karabelas at Focus Communications Investor Relations, leo@fcir.ca, +1 647 689 6041Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.Cautionary Note Regarding Forward-Looking Statements This news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends", "expects" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, the development of GMG's product portfolio and the role of the Technical Advisory Committee in doing so.Such forward-looking statements are based on a number of assumptions of management, including access to capital for growth, growth of sales based on ongoing customer feedback, technical product development and scale-up progress, manufacturing and supply chain can be scaled accordingly, the market will accept and buy the Company's products within the required timeframe, the Company will maintain regulatory compliance and will recruit and retain talent required for growth, the Company will be able to manage geopolitical factors and protect its intellectual property. Additionally, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: financial viability, technical development and scale-up uncertainty, manufacturing and supply chain complexity, market acceptance, regulatory compliance, talent retention, geopolitical factors, and protection of intellectual property. and the risk factors set out under the heading "Risk Factors" in the Company's annual information form dated October 3, 2024 available for review on the Company's profile at www.sedarplus.ca.Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/259441 Copyright 2025 ACN Newswire via SeaPRwire.com.

曼谷，2025年7月21日 - (亞太商訊 via SeaPRwire.com) - 總部位於曼谷的新創公司 Spacely AI 正在將生成式人工智慧引入建築與室內設計領域。該公司近日完成了由 PropTech Farm Fund III 領投的 100 萬美元種子輪融資。參與本輪投資的還包括 P Landscape Co., Ltd. 董事總經理 Wannaporn Phornprapha、UTC Holdings Co., Ltd. 創辦人 Ted Poshakrishna Thirapatana，以及 GitLab 前工程副總裁 Srunyu Stittri。本輪融資是在 SCB 10X 參與的 Pre-Seed 融資之後完成的。這筆資金將用於加速產品開發，並推動公司在全球重點市場的擴展。Spacely AI 種子輪融資資訊圖解Spacely AI 的使命是幫助建築師贏得更多專案、釋放更大的創造力，並降低成本。其雲端工具套件可提供室內與室外空間的 AI 渲染服務、直覺式影像編輯工具、AI 虛擬配置以及自動生成 3D 模型功能。該平台已透過 Extension Warehouse 與 SketchUp 完整整合，並正逐步支援更多主流 CAD 工具，方便專業人士在熟悉的軟體環境中直接使用。「每一家建築事務所都在圍繞 AI 重塑工作流程，」Spacely AI 執行長 Paruey Anadirekkul 表示，「現在的成功取決於你適應得有多快——尤其是當客戶已經在使用這些工具時。」本輪融資將用於推出 Spacely AI 的下一代 2D 轉 3D 自動化引擎，該引擎可減少多達 80% 的人工構思工作，建立美國市場業務，並為全球合作夥伴配備銷售與聯合行銷資源。「如今設計速度決定了成交速度，」PropTech Farm 執行長 Fredrik Bergman 表示，「我們 PropTech Farm 相信，Spacely AI 的即時視覺化能力可以讓猶豫的潛在客戶在第一塊磚尚未落地前就迅速做出購買決策。」P Landscape Co., Ltd. 董事總經理 Wannaporn Phornprapha 補充道：「設計流程往往非常緩慢，Spacely AI 展示了科技如何為真正重要的工作節省時間與精力。」過去一年中，Spacely AI 收入成長了 10 倍，為全球 50 多個國家的 1,500 多家建築與室內設計公司提供服務，生成超過 200 萬張獨特渲染圖。該公司曾榮獲 Krungsri Finno Efra 加速器第一名、Paddle AI Launchpad 最受歡迎獎、SketchUp 創新挑戰賽季軍、Property Portal Watch 大會第一名、Echelon 東南亞百強新創 Top 10、Tech in Asia 新創擂台賽季軍。《The Verge》近期還將 Spacely AI 評為最受設計專業人士推薦的 AI 工具之一。Spacely AI 誠摯邀請全球建築師、室內設計師與房地產從業者將 AI 納入工作流程，體驗前所未有的速度與創意標準。歡迎造訪 spacely.ai 開啟免費試用或預約現場展示。Spacely AI 將與用戶攜手消除瓶頸、激發創意、加速專案落地。關於 Spacely AISpacely AI 是一家將生成式人工智慧引入建築、工程與施工（AEC）產業的 SaaS 公司。Spacely AI 的使命是賦能設計專業人士贏得更多業務、釋放更大創意潛力，並降低專案成本。關於 PropTech FarmPropTech Farm 是一家風險投資公司，專注於投資亞太與歐洲地區處於早期階段的房地產科技公司。該公司由一支具備成功退出經驗的資深團隊所支持，聚焦於在全生命週期內改變建成環境的新創企業——從規劃與建設到物業管理及能源優化。PropTech Farm 結合實戰支援與全球網絡，幫助創業者在複雜且高速成長的市場中拓展創新解決方案。PropTech Farm 第三期基金以 Florissant VCC 的子基金形式設立，由 Swiss-Asia Financial Services 管理。聯絡資訊Nawinda Han行銷hello@spacely.ai來源：Spacely AI Copyright 2025 亞太商訊 via SeaPRwire.com.

杜拜，阿聯酋，2025年7月21日 -（亞太商訊 via SeaPRwire.com）- 31 Concept（簡稱 31C）是一家專注於先進網路智能與流量可視化解決方案的科技初創企業，今日正式宣布脫離隱秘模式（stealth mode）。該公司於2024年12月成功完成600萬美元的 pre-seed 融資，目前已發展為一支由35名世界級專家組成的團隊，並在低調營運期間達成多項關鍵里程碑，包括其旗艦平台的開發。該平台旨在增強數位主權、網路防禦能力及國家基礎設施的可視化水平。在過去數月中，31C 一直處於隱秘開發階段，專注打造一套突破性的網路平台，可實現即時檢查與分類網路流量——即使該流量已被加密。這項先進解決方案的目標客戶包括政府部門、監管機構、執法機關以及大型企業，旨在為其提供對數位通訊與基礎設施活動的深度可視性。該平台將高效能的數據封包級別分析與 AI 驅動的智能系統相結合。在將於2025年9月第一週於新加坡舉行的亞洲資訊安全高峰會（ISS Asia 2025）上，31 Concept 將首次在閉門會議中向政府、監管與執法機構正式展示其平台。此次展示將包括現場演示，直觀呈現 31C 技術如何為國家與數位安全提供關鍵的、可操作的深度洞察。「過去一年我們一直在靜默中構建，如今我們準備好向世界展示我們的成果。」31 Concept 執行長 Misha Hanin 表示，「我們的使命是讓數位基礎設施的守護者重新掌握可視性與控制權——尤其是在這個充滿加密、碎片化與地緣政治不確定性的時代。」31C 在早期獲得的600萬美元 pre-seed 融資來自一位與公司願景及長期創新策略高度契合的成熟策略投資人。自此以來，31C 成功實現了多項技術與商業里程碑，進一步驗證了其平台在真實環境中的可行性與實用價值。31C Research：推動前沿研究的創新引擎31C 的長期創新策略核心是其專屬研究部門——31C Research。該部門位於科學與技術交匯點，由一支全球化的跨學科團隊組成，成員包括量子密碼學博士、數學教授，以及網路安全、網路通訊與人工智慧領域的一線專家。不同於傳統研發團隊，31C Research 的任務不僅限於產品開發，更致力於突破智能流量分析、加密資料解析與抗量子安全框架等技術邊界。該團隊目前已在後量子密碼學、安全通訊及 AI 強化型流量偵測等領域展開深入研究。秉持開放與回饋全球科技生態的理念，31C Research 也將陸續在 GitHub 開源部分內部工具與研究資源，以支持網路安全生態系統中的協作、透明與教育發展。「我們的研究部門體現了我們對技術突破的信念——真正的飛躍來自嚴謹科學與現實迫切性的結合。」31C 首席技術官 Boriss Heismann 表示，「我們打造的不是當下的解決方案，而是下一時代網路安全與數位防禦的基礎。」聯絡資訊Misha Hanin執行長（CEO）misha.hanin@31c.io來源：31 Concept Copyright 2025 亞太商訊 via SeaPRwire.com.

SAN DIEGO, CA, July 22, 2025 - (ACN Newswire via SeaPRwire.com) - Source Intelligence has launched its EUDR solution to help companies simplify deforestation risk management and automate compliance workflows ahead of upcoming enforcement deadlines. Purpose-built for the European Union Deforestation Regulation (EUDR), the SaaS-based solution enables businesses to streamline supply chain traceability, risk assessment, and due diligence reporting. As companies prepare for the regulation's requirements, failure to comply could result in fines of up to 4% of annual turnover, making early action essential.Source Intelligence Logo Source Intelligence's logo and "Trust your source" taglineSource Intelligence's solution enables companies to implement an end-to-end EUDR due diligence workflow, from tracing product origins and validating supplier data to identifying deforestation risk and submitting due diligence statements. A direct integration with the EU TRACES platform allows Source Intelligence to submit statements on behalf of clients as an authorized representative, helping companies streamline final reporting requirements.With Source Intelligence's EUDR solution, companies can:Enhance supply chain visibility by mapping sub-tier relationships and tracking sourcing activity in real timeIdentify deforestation risks faster using Article 9-aligned scoring and multi-source environmental datasetsImprove efficiency through automation and a direct connection to EU TRACESReduce compliance risk by proactively flagging high-risk suppliers and sourcing areas using satellite imagery and customizable risk modelsThe platform's satellite-powered deforestation detection tools assess land use change with precision and provide actionable insights for risk mitigation. These capabilities are bolstered by real-time data validation, customizable risk assessments, and centralized documentation-all designed to help companies operationalize the three-step due diligence process outlined by the European Commission."The EUDR requires companies to reach deeper into their supply chains, gather more specific data, and act on risk with greater speed," said Mike Flynn, Chief Product Officer at Source Intelligence. "Our solution is designed to make that process manageable-combining automation, advanced risk screening, and satellite monitoring to help businesses take control of their due diligence obligations before enforcement begins."While the EUDR is already in force, operators and traders must fully implement the required due diligence process by December 30, 2025. Micro and small enterprises have until June 30, 2026. With deadlines fast approaching, Source Intelligence offers a streamlined path to readiness. Interested organizations are invited to schedule a demo and experience the advanced EUDR solution firsthand.About Source IntelligenceSource Intelligence is the leading provider of AI-driven supply chain compliance and sustainability software. Built for mid-market and enterprise manufacturers, our configurable SaaS platform centralizes supply chain data, automates regulatory workflows, and scales with program maturity. Our software blends AI and in-house expert oversight to deliver efficiency without compromising accuracy. From product compliance and EPR to conflict minerals and component obsolescence, we help global compliance teams reduce risk, improve visibility, and meet evolving obligations with confidence. Learn more at www.sourceintelligence.com.Contact InformationAmanda LindbergDirector of Marketingamanda.lindberg@sourceintel.comSOURCE: Source Intelligence Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, July 20, 2025 - (ACN Newswire via SeaPRwire.com) - As the Hong Kong Observatory will consider issuing Strong Wind Signal No. 3 between 7 and 9 pm, the Hong Kong Book Fair, Hong Kong Sports and Leisure Expo and World of Snacks will reopen earlier to the public at 9am tomorrow (21 July), with extended evening hours, allowing residents and tourists to immerse themselves in the worlds of literature, sports and leisure activities and snacks with a single ticket. The opening hours for the remaining two days of the fairs are as follows:21 July- The Hong Kong Book Fair will open earlier at 9am and will be extended and close at 11pm.- The Hong Kong Sports and Leisure Expo and World of Snacks will open earlier at 9am and will be extended and close at 10pm.22 July- The three fairs will open from 9am to 5pm.Admission tickets purchased on 20 July can be used within the remaining fair days. Alternatively, ticket holders may request a refund upon presentation of unused valid tickets. VIP tickets and complimentary tickets are not eligible for refunds. Refund arrangements will be announced on the Book Fair website (www.hkbookfair.com).Media enquiriesHong Kong Book Fair, Hong Kong Sports and Leisure Expo and World of SnacksYuan Tung Financial Relations:Agnes Yiu Tel: (852) 3428 5690 Email: ayiu@yuantung.com.hkSalina Cheng Tel: (852) 3428 2362 Email: salcheng@yuantung.com.hkHKTDC Communications & Public Affairs Department:Snowy Chan Tel: (852) 2584 4525 Email: snowy.sn.chan@hktdc.orgSerena Cheung Tel: (852) 2584 4272 Email: serena.hm.cheung@hktdc.orgHong Kong Sports and Leisure Expo, World of SnacksHKTDC Communications & Public Affairs Department:Stanley So Tel: (852)2584 4049 Email: stanley.hp.so@hktdc.orgJane Cheung Tel: (852) 2584 4137 Email: jane.mh.cheung@hktdc.orgHKTDC Media Room: http://mediaroom.hktdc.comAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferencesand business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, July 19, 2025 - (ACN Newswire via SeaPRwire.com) - As the Hong Kong Observatory has announced that the Tropical Cyclone Warning Signal No. 8 will be issued at 12:20am on 20 July, the Hong Kong Book Fair, Hong Kong Sports and Leisure Expo and World of Snacks will close temporarily tomorrow (20 July).After consulting with exhibitors and considering the prevailing circumstances, the following adjustments will be made by the HKTDC for the benefit of visitors and exhibitors:If the Tropical Cyclone Warning Signal No. 8 is cancelled at or before 4:30pm on 20 July, the fairs will re-open to the public two hours after the signal is cancelled. The opening hours of the fairs will be adjusted as below:20 July- The Hong Kong Book Fair will be extended and close at 11pm.- The Hong Kong Sports and Leisure Expo and World of Snacks will be extended by one hour and close at 10pm.21 July- The Hong Kong Book Fair will open earlier at 9am and will be extended and close at 11pm.- The Hong Kong Sports and Leisure Expo and World of Snacks will open earlier at 9am and will be extended and close at 10pm.The fairs, however, will remain closed for the day if the Tropical Cyclone Warning Signal No. 8 is cancelled after 4:30pm on 20 July. The opening hours of the fairs on 21 July will be adjusted as below:- The Hong Kong Book Fair will open earlier at 9am and will be extended and close at 11pm.- The Hong Kong Sports and Leisure Expo and World of Snacks will open earlier at 9am and will be extended and close at 10pm.The opening hours on 22 July will remain as normal, with all three fairs open from 9am to 5pm.Media enquiriesHong Kong Book Fair, Hong Kong Sports and Leisure Expo and World of SnacksYuan Tung Financial Relations:Agnes Yiu Tel: (852) 3428 5690 Email: ayiu@yuantung.com.hkSalina Cheng Tel: (852) 3428 2362 Email: salcheng@yuantung.com.hkHKTDC Communications & Public Affairs Department:Snowy Chan Tel: (852) 2584 4525 Email: snowy.sn.chan@hktdc.orgSerena Cheung Tel: (852) 2584 4272 Email: serena.hm.cheung@hktdc.orgHong Kong Sports and Leisure Expo, World of SnacksHKTDC Communications & Public Affairs Department:Stanley So Tel: (852)2584 4049 Email: stanley.hp.so@hktdc.orgJane Cheung Tel: (852) 2584 4137 Email: jane.mh.cheung@hktdc.orgHKTDC Media Room: http://mediaroom.hktdc.comAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2025 ACN Newswire via SeaPRwire.com.

香港，2025年7月18日 - (亞太商訊 via SeaPRwire.com) - 憑藉十年間服務中國大部分頭部銀行的實戰經驗，第四範式在香港穩定幣即將落地之際，前瞻性地錨定其系列需求，於今日推出「穩定幣智能風控&智能合規解決方案」，為這一風頭正勁的數字資產建起安全護城河。相關分析報告顯示，將於8月1日正式生效的香港《穩定幣條例》，初期僅會批出個位數牌照。主管部門會審查申請機構的儲備管理能力、合規體系與技術安全性等情況。值得注意的是，香港《穩定幣條例草案》已明確將「反洗錢要求」列為牌照申請的必備要求之一。穩定幣的「安全性」已然成為其能否「穩定」的重要衡量。穩定幣市場爆發式增長，風險隱患同步顯現近期，穩定幣成為全球金融科技領域炙手可熱的賽道。香港《穩定幣條例》於2025年5月正式立法，成為全球首個全鏈條監管框架；美國《GENIUS法案》同期推進，要求發行方以高流動性資產（如美元現金、短期美債）作為儲備；6月5日，全球第二大穩定幣USDC的發行商Circle以31美元發行價登陸紐交所，僅上市1個月Circle市值飆升接近7倍，成為美股現象級暴漲標的。政策驅動下，螞蟻、京東、渣打等巨頭紛紛入局，全球穩定幣市值突破2400億美元，年交易額達35萬億美元，超越Visa等傳統支付網絡。憑藉分鐘級跨境結算（成本僅為傳統模式10%）和7X24小時即時支付的優勢，穩定幣已然成為企業跨境貿易的核心基礎設施。穩定幣的本質：人人都能懂的「數字現金」穩定幣（Stablecoin）是一種價值錨定現實資產（如美元、黃金）的加密貨幣。其核心邏輯是通過儲備抵押或演算法調控，將價格波動控制在極小範圍，成為連接傳統金融與加密經濟的「穩定橋樑」。風光背後，風險暗湧- 欺詐與洗錢漏洞：不法分子借「穩定幣」概念包裝殺豬盤、偽造投資項目，甚至仿冒企業名義騙取資金- 技術安全挑戰：遠端控制、螢幕共用等新型電詐手段頻現，用戶資產面臨被盜風險穩定幣的「穩定」不僅依賴錨定機制，更需構建覆蓋發行、流通、兌付的全週期風控體系。AI「聯姻」穩定幣：智能守護安全更高效當前，AI正深度重構穩定幣生態，助推其智能化升級（1）智能監管合規- 政策動態感知：AI演算法自動解析全球監管檔（如香港《穩定幣條例》、美國《GENIUS法案》），動態調整合規參數，自動生成合規策略，提高回應速度- 鏈上行為預判：AI系統通過大資料和機器學習，即時監控跨境資金流、社交媒體與鏈上資料，提前預警「穩定幣脫錨」「仿冒專案詐騙」等風險，降低損失率（2）精准反欺詐- 多模態風險識別：融合交易圖譜、位址聚類、行為偏離分析，精准定位洗錢團夥- 自我調整風控規則：AI動態優化反洗錢規則庫，應對新型詐騙手段（如遠程操控、混幣器轉移贓款），彌補人工規則更新滯後缺陷金融基因導向 命中註定就是你第四範式能在這麼短的時間內，推出「穩定幣智能風控&智能合規解決方案」，源於其深厚的金融基因與強大的全棧式AI技術支援。依託十年間為各大銀行服務積累下來的豐富實戰經驗，精准洞察穩定幣生態的風險點；同時，強大的AI技術能力使傳統銀行的合規能力與區塊鏈技術深度融合成為可能，最終才得以如此神速推出「穩定幣智能風控&智能合規解決方案」。該方案的兩大支柱源於具有範式特色的智能反洗錢系統和交易反欺詐解決方案。賦能合規，助力穩定幣平穩前行任何虛擬貨幣投資都像「開賽車」，刺激但危險，上車前務必系好「風險意識」的安全帶！而穩定幣作為數位金融的新引擎，其安全交易更需匹配智能化的「AI防護盾」。深耕金融安全多年的第四範式，以AI技術為矛、資料洞察為盾，推出「穩定幣智能風控&智能合規解決方案」，為這一新興形態構建即時風險感知與自我調整防禦體系，築牢動態化交易安全屏障、助力穩定幣合規發展之路。第四範式是領先的人工智能技術與服務提供者、資料科技驅動行業應用的創新者，在AutoML、遷移學習等技術領域的探索及實踐具有國際前瞻性。基於機器學習技術及行業應用經驗，能夠對資料進行更加精確的挖掘與預測，揭示出資料背後隱藏的海量規則，説明企業實現智能變革，提升運營效率。作為金融科技風控領域的標杆企業，第四范式已於十年間服務多家中國頭部銀行，累計攔截欺詐交易超百億元。更是在政府、能源、製造、零售、醫療、媒體、教育、互聯網等領域有近2000個成功落地案例。 Copyright 2025 亞太商訊 via SeaPRwire.com.

HONG KONG, July 17, 2025 - (ACN Newswire via SeaPRwire.com) - The 35th HKTDC Hong Kong Book Fair opened yesterday alongside the 8th HKTDC Sports and Leisure Expo and the 5th HKTDC World of Snacks. The three events, which have attracted more than 770 exhibitors, are running until 22 July at the Hong Kong Convention and Exhibition Centre (HKCEC).To reinforce Hong Kong's position as a regional intellectual property (IP) trading centre, the HKTDC is hosting a series of onsite sales and cultural activities during the fairs. Notably, today’s IP Roundtable and International Publishing Forum provide a platform for industry professionals from 12 countries and regions to explore market trends and exchange insights. Both events are sponsored by the Cultural and Creative Industries Development Agency of the Government of the Hong Kong Special Administrative Region (HKSAR), attracting an audience of over 220 publishing professionals and enthusiasts and further strengthening Hong Kong's role as a regional IP trading centre.Organised by the HKTDC and co-organised by the Hong Kong Reprographic Rights Licensing Society (HKRRLS), the IP Roundtable ran under the theme “A Forward-Looking Copyright Framework – How to Balance Interests Between Innovation and IP Protection”, focusing on how different regions are developing forward-looking copyright frameworks in response to the advancement of artificial intelligence (AI). This year’s event introduced a new business matching session that facilitated over 70 meetings to promote copyright trading and generate commercial opportunities for participants. The event opened with welcome remarks from Jenny Koo, Assistant Executive Director of the HKTDC, followed by opening remarks from Dr Sharon Wong, Executive Director, HKRRLS, who also moderated the discussion session.The panel discussion featured five distinguished speakers from the UAE, Belgium, Singapore, Japan and the United Kingdom, including Majd Hassan Al Shehhi, Director of The Emirates Reprographic Rights Management Association (ERRA); Sarah Tran, Head of Regional Policy and Public Affairs of the International Federation of Reproduction Rights Organisations (IFRRO); Andrew Fong, CEO of the Copyright Licensing and Administration Society of Singapore (CLASS); Toshimichi Ishijima, Secretary General of the Japan Academic Association for Copyright Clearance (JAC); and James Bennett, Head of Rightsholder Relations of The Copyright Licensing Agency (CLA).Majd Hassan Al Shehhi, Director of ERRA, said: “The Hong Kong Book Fair brings together publishers from different places. Unlike other international book fairs that focus on B2B [business-to-business], the Hong Kong Book Fair serves as a B2C [business-to-consumer] platform. I am very happy to participate in the IP Roundtable as it provides an invaluable platform for industry professionals to gain insights into the publishing and IP sectors and explore new business opportunities.” She added that Hong Kong's robust IP protection system and world-class professional services make the city well positioned to act as a regional IP trading centre, viewing it as a great example.The HKTDC joined with the Hong Kong Publishing Federation Limited to organise the International Publishing Forum today, running under the theme “AI and Publishing”. The event opened with remarks by Anita Wan, Convenor of the Book Fair Committee of the Hong Kong Publishing Federation Limited. Featured speakers included Xin Guangwei, former Editor-in-Chief of People’s Publishing House; Qu Hongbin, Director and President of Guomai Culture Media Co., Ltd; and Wayne Press, Global Product Director of Oxford University Press. The Q&A session that followed, moderated by Chan Ka-yeung, Director of City University of Hong Kong Press, was lively and in-depth, exploring how the publishing industry can respond to the opportunities and challenges posed by AI.Photo download: http://bit.ly/3TKAZKIThe IP Roundtable, themed A Forward-Looking Copyright Framework – How to Balance Interest Between Innovation and IP Protection”, focused on how different regions are developing forward-looking copyright frameworks in response to AI advances.The IP Roundtable introduced a new business matching session this year, facilitating over 70 meetings to promote copyright trading and create commercial opportunities for participants.The International Publishing Forum ran under the theme “AI and Publishing”, exploring how the publishing industry can respond to the opportunities and challenges posed by AI.Disclaimer: The Government of the Hong Kong Special Administrative Region provides funding support to the project only, and does not otherwise take part in the project. Any opinions, findings, conclusions or recommendations expressed in these materials/events (or by members of the project team) are those of the project organisers only and do not reflect the views of the Government of the Hong Kong Special Administrative Region, the Culture, Sports and Tourism Bureau, the Cultural and Creative Industries Development Agency, the CreateSmart Initiative Secretariat or the CreateSmart Initiative Vetting Committee.Media enquiriesHong Kong Book Fair, Hong Kong Sports and Leisure Expo and World of SnacksYuan Tung Financial Relations:Agnes Yiu Tel: (852) 3428 5690 Email: ayiu@yuantung.com.hkSalina Cheng Tel: (852) 3428 2362 Email: salcheng@yuantung.com.hkHKTDC’s Communications & Public Affairs Department:Snowy Chan Tel: (852) 2584 4525 Email: snowy.sn.chan@hktdc.orgSerena Cheung Tel: (852) 2584 4272 Email: serena.hm.cheung@hktdc.orgHong Kong Sports and Leisure Expo, World of SnacksHKTDC’s Communications & Public Affairs Department:Stanley So Tel: (852)2584 4049 Email: stanley.hp.so@hktdc.orgJane Cheung Tel: (852) 2584 4137 Email: jane.mh.cheung@hktdc.orgHKTDC Media Room: http://mediaroom.hktdc.comAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit:www.hktdc.com/aboutus. Copyright 2025 ACN Newswire via SeaPRwire.com.

Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - July 16, 2025) - Doubleview Gold Corp (TSXV: DBG) (OTCQB: DBLVF) (WKN: LA1W038) (FSE: 1D4) ("Doubleview" or the "Company") is pleased to provide a detailed update on its 100%-owned polymetallic Hat Deposit strategically located in northwestern British Columbia, Canada.Polymetallic Hat Deposit — Momentum Builds for Resource Enhancement and Scandium MetallurgyThe Company is currently executing its most extensive field activities to date at the Hat Project. The 2025 drill campaign is well underway and seamlessly connecting to the successes of the previous seasons, significantly advancing our geological understanding and laying a robust foundation for an updated mineral resource estimate which will be part of the preliminary economic assessment.In the Company's ongoing 2025 exploration program, Doubleview has completed 4,500 meters of diamond drilling across 7 new holes, with an average depth of approximately 665 meters. This includes drill hole H096, which impressively reached a total depth of 922.5 meters. These efforts have successfully targeted intended zones within the deposit, providing invaluable information for resource modeling and estimation. The drill core photos at the end of this news release show a few select mineralization intercepts.Looking ahead, the next phases of drilling will focus on evaluating the eastern edges and reaching into the deeper parts of the Hat deposit, with the objective of further expanding the known mineralization footprint and understanding the genesis of the deposit.Scandium Recovery Studies — A Strategic PriorityGiven the critical importance of scandium — a highly sought-after rare earth mineral in North America — Doubleview is placing special emphasis on its extraction and recovery from Hat deposit with the objective of developing an achievable process to produce an economical and marketable product.Three accredited professional metallurgical facilities are independently conducting parallel testwork on the Hat Deposit's samples. Diverse methodologies are employed during the bulk processing by each entity. While final results are anticipated, interim meetings and discussions have been extremely encouraging, suggesting significant recovery potential for scandium. These studies are integral to the mineral resource evaluation and will define the best marketable product.Preliminary Economic Assessment (PEA) The Preliminary Economic Assessment (PEA) for the Hat Deposit is currently underway across several disciplines. This includes incorporating the updated Mineral Resource Estimate (MRE) Version 2, which will integrate all drill hole results of the 2024 drill campaign. Many other aspects of the mineral deposit's final modeling and evaluation are simultaneously progressing. Notably, scandium would potentially be added to the resource evaluation, which could further enhance the project's economic outcome. The completed PEA will represent the conclusion of the due diligence process for several interested parties that may potentially join the Company in developing the Hat Deposit.Environmental and Permitting Pathway AdvancesIn a forward-looking initiative, Doubleview commissioned environmental baseline studies to a leading engineering company. This work includes the design of an environmental permitting road map for the Hat Project. The goal is to ensure all data is collected within the guidelines of relevant future permitting processes. This early-stage information is vital for forthcoming advanced studies designed to help the project progress efficiently.Archaeological Impact Assessment studies (AIA) have successfully been completed and accepted by the Archaeology Branch of British Columbia. The presented results of these studies are an important step in journey of the development of the Hat Project.Executive Commentary:Farshad Shirvani, M.Sc., Geology, President and CEO of Doubleview Gold Corp:"Our commitment to advancing critical mineral projects is unwavering. The ongoing work at our Hat deposit, from aggressive drilling to pioneering scandium metallurgy, underscores our dedication to creating long-term value for all stakeholders. We are building a robust foundation for the future, strategically positioning Doubleview at the forefront of the polymetallic and critical minerals landscape in British Columbia.The exciting developments at the Hat Project have garnered significant interest with globally leading investment entities, sovereign wealth funds, as well as top-tier mining companies who envision themselves as pillars of the future of critical metals, such as scandium, copper and cobalt. This led to promising high-level discussions with these interested parties. We find ourselves at a unique juncture, and I strongly believe we are diligently exploring all opportunities presented to us to maximize our shareholders' success."Drill core photos of a few select mineralization interceptsTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8003/259000_img1.jpgTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8003/259000_img2.jpgTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8003/259000_img3.jpgTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8003/259000_img4.jpgTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8003/259000_img5.jpgTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8003/259000_img6.jpgTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8003/259000_img7.jpgTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8003/259000_img8.jpgTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8003/259000_img9.jpgTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8003/259000_img10.jpgAbout Doubleview Gold CorpDoubleview Gold Corp, TSX-Venture Exchange (TSXV: DBG) (OTCQB: DBLVF) (WKN: LA1W038) (FSE: 1D4). is a Canadian-based mineral resource exploration and development company focused on the discovery and advancement of high-value mineral deposits in British Columbia. The Company controls a portfolio of prospective mineral properties, including the Hat polymetallic deposit and the Red Spring copper-gold-silver project.About the Hat Polymetallic DepositThe Hat Deposit, located in northwestern British Columbia, is a polymetallic porphyry project with major resources of copper, gold, cobalt, and the potential for scandium. As one of the region's significant sources of critical minerals, the Hat deposit has undergone targeted exploration and development. The 0.2% CuEq cut-off resource estimate, as of the recently completed Mineral Resource Estimate and the Company's July 25, 2024, news release, is summarized below:Open Pit Model HatResource CategoryTonnageAverage GradeMetal ContentCuEqCuCoAuAgCuEqCuCoAuAgMt%%%g/tg/tmillion lbmillion lbmillion lbthousand ozthousand ozIn PitIndicated1500.4080.2210.0080.190.421,353733289292,045Inferred4770.3440.1850.0090.150.493,6191,945912,3287,575 Scandium potential for the Hat Deposit is estimated to be 300 to 500 million tonnes at an average grade of 40 ppm (0.004%) Sc2O3.For further details, please refer to the Company's July 25, 2024 news release.Qualified Person:Erik Ostensoe, P. Geo., a consulting geologist, and Doubleview's Qualified Person with respect to the Hat Project as defined by National Instrument 43-101 Standards of Disclosure for Mineral Projects, has reviewed, and approved the written technical disclosure contained in the news release. He is not independent of Doubleview as he is a shareholder in the company.On behalf of the Board of Directors,Farshad Shirvani, President & Chief Executive OfficerFor further information please contact:Doubleview Gold CorpVancouver, BC Farshad ShirvaniPresident & CEOT: (604) 678-9587E: corporate@doubleview.caWebsite: www.doubleview.caNEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.Certain of the statements made and information contained herein may constitute "forward-looking information." In particular references to the private placement and future work programs or expectations on the quality or results of such work programs are subject to risks associated with operations on the property, exploration activity generally, equipment limitations and availability, as well as other risks that we may not be currently aware of. Accordingly, readers are advised not to place undue reliance on forward-looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information, whether as a result of new information, future events or otherwise.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/259000 Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, July 17, 2025 - (ACN Newswire via SeaPRwire.com) - Cornerstone Robotics (CSR), a leading medical innovator in precision surgical systems, signed a tripartite Memorandum of Understanding (MOU) with the National Healthcare Group PTE LTD (NHG Health) and the Lee Kong Chian School of Medicine (LKCMedicine) of Nanyang Technological University, Singapore to facilitate healthcare advancement in Singapore through collaboration in robotic-assisted surgery (RAS) in clinical research and application, surgical education, and healthcare innovation.Front row (from Left): Alexis Cheng, Co-Founder & Vice President of Operation and Business Strategy of Cornerstone Robotics, Professor Joe Sim, Group CEO, NHG, Professor Joseph Sung, Dean, Lee Kong Chian School of Medicine; Back row (from left): Jerry Wang, Co-Founder, CTO & COO of Cornerstone Robotics, Professor Lam Khin Yong, Vice President (Industry), Mr. Ong Ye Kung, Minister of Health and Coordinating Minister for Social Policy, Mr. Tan Tee How, Chairman, NHG The MOU, signed at the opening of CHI Innovate 2025 under the witness of Mr Ong Ye Kung, Minister for Health of Singapore, outlines that the three parties will jointly focus on two strategic areas: research in tele-surgical education and training, as well as cost-effectiveness studies which facilitate extending the accessibility of RAS.RAS is an important pillar of minimally invasive care. It is reshaping the field by improving precision in surgery through adopting high resolution imaging, smart algorithms, and the finest control of instruments, RAS results in better patient outcomes such as less invasiveness and fast recovery.As an innovator in this transformation, Cornerstone Robotics’ Sentire® Endoscopic Surgical Robot (C1000) is wholly developed in-house. It has completed clinical trials in Mainland China and Hong Kong and has received National Medical Products Administration (NMPA) approval for clinical applications.The MOU represents a significant milestone in Cornerstone Robotics’ vision of “forging accessibility of robotic surgery” alongside its partnership with the Faculty of Medicine of The Chinese University of Hong Kong (CUHK).Professor Samuel Au, Founder and CEO of Cornerstone Robotics, said, “We are honoured to collaborate with NHG Health and LKCMedicine to further advance RAS in Singapore. By integrating precision engineering, intelligent algorithms, and insights from frontline surgeons, Cornerstone Robotics is dedicated to making advanced surgical robotic technology accessible to patients around the world.”Looking ahead, the three parties will continue to strengthen their collaboration to drive innovation, expand clinical impact, and cultivate surgical talent — working together to shape a smarter, more accessible future for surgical care across the region and beyond.About Cornerstone Robotics Limited (CSR)Cornerstone Robotics (CSR) is leading medical innovations to create a healthier world by advancing surgical care with cutting-edge robotic systems that make high-quality healthcare more accessible and efficient for everyone globally. Founded in 2019, CSR has assembled a global team of surgical robotics experts, clinical professionals, and multidisciplinary innovators, driving rapid growth with key hubs in Hong Kong, Shenzhen, Beijing, Shanghai, Boston (US), and Amsterdam (NL), alongside an R&D collaboration hub in Portsmouth (UK). With multiple development pipelines, we are pioneering robotic solutions for soft tissue and other surgical specialties.To find out more information, please visit our website at https://en.csrbtx.com/ .About NHG HealthNHG Health is a leading public healthcare provider in Singapore recognised for its quality clinical care and its commitment in enabling healthier lives through preventive health, innovative solutions and person-centred programmes tailored to every life stage. Our integrated health system, which spans primary care, hospitals and national specialty centres, includes Tan Tock Seng Hospital, Khoo Teck Puat Hospital, Woodlands Health, Yishun Community Hospital, NHG Polyclinics, the Institute of Mental Health, National Skin Centre and the National Centre for Infectious Diseases. Together with academic and industry partners, we advance medical education, research and healthcare innovation in Singapore, addressing areas that are critical to Singapore’s population needs. As the Regional Health Manager for Central and North Singapore, NHG Health partners general practices and health and social care agencies to ensure the physical, mental and social well-being of residents in the community. Together, we are committed to building healthier and resilient communities and Adding Years of Healthy Life to the people we serve.More information at www.nhghealth.com.sg.About Nanyang Technological University, Singapore (NTU Singapore)A research-intensive public university, Nanyang Technological University, Singapore (NTU Singapore) has 35,000 undergraduate and postgraduate students in the Business, Computing & Data Science, Engineering, Humanities, Arts, & Social Sciences, Medicine, Science, and Graduate colleges. NTU is also home to world-renowned autonomous institutes – the National Institute of Education, S Rajaratnam School of International Studies and Singapore Centre for Environmental Life Sciences Engineering – and various leading research centres such as the Earth Observatory of Singapore, Nanyang Environment & Water Research Institute and Energy Research Institute @ NTU (ERI@N). Under the NTU Smart Campus vision, the University harnesses the power of digital technology and tech-enabled solutions to support better learning and living experiences, the discovery of new knowledge, and the sustainability of resources. Ranked amongst the world’s top universities, the University’s main campus is also frequently listed among the world’s most beautiful. Known for its sustainability, NTU has achieved 100% Green Mark Platinum certification for all its eligible building projects. Apart from its main campus, NTU also has a medical campus in Novena, Singapore’s healthcare district.For more information, please visit website www.ntu.edu.sg. Copyright 2025 ACN Newswire via SeaPRwire.com.

SAN DIEGO, CA, July 18, 2025 - (ACN Newswire via SeaPRwire.com) - General Atomics Aeronautical Systems, Inc. (GA-ASI) and General Atomics Integrated Intelligence, Inc. (GA-Intelligence) successfully completed a groundbreaking demonstration on July 8, integrating technologies across multiple affiliates to showcase long-range kill chain effects, including an autonomous air-to-air engagement. The flight integrated local and global sensor fusion to deliver real-time situational awareness and autonomous tasking to an airborne MQ-20 Avenger® through the Tactical Autonomy Core Ecosystem (TacACE) to close the kill chain and showcase the system's maturity and operational readiness for the warfighter.The event featured the integration of a Collaborative Combat Aircraft (CCA), a fully compliant government-owned autonomy implementation, and beyond-line-of-sight (BLOS) Command and Control (C2). The MQ-20 unmanned jet, furnished by GA-ASI, acted as a CCA surrogate in a sensor Emission Control (EMCON) environment. It was operated autonomously and controlled using distributed-edge C2 nodes powered by Optix.C2 and Omniview software. Optix.C2, a product from General Atomics-Intelligence, provided low-latency, localized C2 functionality while remaining networked to the broader operational picture, enabling real-time coordination across multiple domains.Dr. Brian Ralston, President of GA-Intelligence, applauded the joint effort. "This demonstration illustrates the value of integrating cutting-edge and proven technologies across the GA enterprise. The Optix data platform and C2 capability enable rapid integration and experimentation to address critical DoD and IC needs."General Atomics successfully fused space-based sensing and tactical sensing with the C2 node during the flight, giving the aircraft access to a complete real-time threat picture for enhanced onboard autonomous decision-making. The demonstration also included live coordination of Intelligence, Surveillance, and Reconnaissance (ISR) and kinetic tasking through a unified operator interface capable of deployment in virtually any cloud environment.During the exercise, the live MQ-20 aircraft autonomously patrolled a designated Combat Air Patrol (CAP) zone, leveraging off-board sensors to demonstrate how passive collection techniques can inform autonomous platforms in real time. Four CCA surrogates - one live and three virtual - were directed by an operator to investigate multiple targets of interest. Upon identifying them as threats, the operator issued a command to initiate the BLOS engagement. The autonomous systems maneuvered into position, simulated missile launches, assessed battle damage, and returned to CAP without additional operator input."This demonstration represents a substantial leap in autonomy and human-machine interfaces that are critical to the warfighter in the near-peer fight," said Michael Atwood, Vice President of Advanced Programs at GA-ASI. "By integrating Optix.C2 with TacACE, we're delivering a system that not only operates at the tactical edge but also enables rapid decision-making and execution across the battlespace. This is the future of warfare - scalable, autonomous systems that empower the warfighter to dominate at range."GA-ASI continues to develop and validate autonomy products that deliver scalable, collaborative aircraft behavior with minimal operator input. GA-Intelligence provided multi-sensor global fusion and engagement orchestration algorithms and interfaces. This latest milestone expands the company's autonomy portfolio with access to a complete threat picture while advancing critical-edge C2 capabilities and intuitive operator interfaces.About GA-ASIGeneral Atomics Aeronautical Systems, Inc. is the world's foremost builder of Unmanned Aircraft Systems (UAS). Logging more than 8 million flight hours, the Predator® line of UAS has flown for over 30 years and includes MQ-9A Reaper®, MQ-1C Gray Eagle®, MQ-20 Avenger®, and MQ-9B SkyGuardian®/SeaGuardian®. The company is dedicated to providing long-endurance, multi-mission solutions that deliver persistent situational awareness and rapid strike.For more information, visit www.ga-asi.com.Avenger, EagleEye, Gray Eagle, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are trademarks of General Atomics Aeronautical Systems, Inc., registered in the United States and/or other countries.About GA-IntelligenceGeneral Atomics Integrated Intelligence, Inc. is a data science, software development, and systems engineering firm focused on developing advanced analytic capabilities to customers in both public and private sectors, with a strong emphasis on tools in support of spatio-temporal (space and time) data management, multi-source/multi-INT correlation and data fusion, tracking, entity resolution, location forecasting, and multi-domain global situational awareness (MDGSA) leveraging extremely high volume/velocity data sources. For more information, visit www.ga-intelligence.com.Contact InformationGA-ASI Media Relationsasi-mediarelations@ga-asi.com(858) 524-8101SOURCE: General Atomics Aeronautical Systems, Inc. Copyright 2025 ACN Newswire via SeaPRwire.com.

SAN FRANCISCO, CA, July 18, 2025 - (ACN Newswire via SeaPRwire.com) - The first Belgian aircrew has completed training to operate the world's leading remotely piloted aircraft (RPA): the MQ-9B SkyGuardian®. General Atomics Aeronautical Systems, Inc. (GA-ASI), designer and developer of the MQ-9B, provided the extensive aircrew training that culminated at GA-ASI's Desert Horizon test facility in El Mirage, California, following stops in Belgium and GA-ASI's Flight Test & Training Center in North Dakota."Providing all-encompassing training for the aircrews of our customers goes hand in hand with delivering the world's most capable RPA," said GA-ASI President David R. Alexander. "Completing this training ensures that Belgium is ready and able to operate their MQ-9Bs and maximize the benefits that come from long-range, high-endurance RPA."The scope of the training is focused on the foundational skills required to operate the MQ-9B SkyGuardian air vehicle and its equipment, including the Multi-Spectral Targeting System (MTS), Synthetic Aperture Radar (SAR), Mission Intelligence Station (MIS), and System for Tasking and Real-Time Exploitation (STARE). Training involves building solid foundations for both normal and emergency operations in Intelligence, Surveillance, and Reconnaissance (ISR) systems, instrument flying, and Automatic Takeoff and Landing Capability (ATLC) and more.The first flight of Belgium's initial MQ-9B aircraft took place in February. That aircraft will soon complete Acceptance Test Procedures and is expected to be in Belgium before the end of September. It's the first of a four-aircraft purchase by the Belgian Ministry of Defence. The Foreign Military Sale to Belgium also includes two Certified Ground Control Stations.MQ-9B is the world's most advanced RPA system, delivering exceptionally long endurance and range - with ATLC under pole-to-pole SATCOM-only control - and will be able to operate in unsegregated airspace using the GA-ASI-developed Detect and Avoid system. MQ-9B includes the SkyGuardian and SeaGuardian® models, with multiple deliveries made to the U.K.'s Royal Air Force (Protector), as well as orders from Canada, Poland, Japan, Taiwan, India, and the U.S. Air Force in support of the Special Operations Command. MQ-9B has also supported various U.S. Navy exercises, including Northern Edge, Integrated Battle Problem, and Group Sail.About GA-ASIGeneral Atomics Aeronautical Systems, Inc., is the world's foremost builder of Unmanned Aircraft Systems (UAS). Logging more than 8 million flight hours, the Predator® line of UAS has flown for over 30 years and includes MQ-9A Reaper®, MQ-1C Gray Eagle®, MQ-20 Avenger®, and MQ-9B SkyGuardian®/SeaGuardian®. The company is dedicated to providing long-endurance, multi-mission solutions that deliver persistent situational awareness and rapid strike.For more information, visit www.ga-asi.com.Avenger, EagleEye, Gray Eagle, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are trademarks of General Atomics Aeronautical Systems, Inc., registered in the United States and/or other countries.Contact InformationGA-ASI Media Relationsasi-mediarelations@ga-asi.com(858) 524-8101SOURCE: General Atomics Aeronautical Systems, Inc. Copyright 2025 ACN Newswire via SeaPRwire.com.

FAIRFORD, UK, July 18, 2025 - (ACN Newswire via SeaPRwire.com) - General Atomics is taking a bold step toward rapidly delivering a European Collaborative Combat Aircraft (CCA) - based on a mature U.S. platform, assembled in Europe, with European mission systems - by aligning its independent U.S. and German aerospace affiliates under a teamed operation.YFQ-42AThe new aircraft is derived from the U.S. Air Force's YFQ-42A prototype, currently in ground testing and scheduled for first flight later this summer, designed and built by General Atomics Aeronautical Systems, Inc. (GA-ASI) in San Diego, Calif. European mission system customization and manufacturing in Europe will be supported by General Atomics' German aerospace affiliate, General Atomics Aerotec Systems GmbH (GA-ATS), headquartered in Oberpfaffenhofen, near Munich.Leveraging the prior investments of these established aerospace companies on both sides of the Atlantic provides a jump start for European uncrewed fighter development and a pathway to meet the speedy acquisition timelines set by European nations. It also provides an established path for further international collaboration efforts and indigenous defense partnerships, based on both companies' previous successes in global aircraft delivery."We're eager to combine our uncrewed aircraft system expertise with the airborne sensor and weapons system expertise of the European defense industry, starting with our own affiliate GA Aerotec Systems GmbH in Germany," said GA-ASI CEO Linden Blue. "With a proven CCA design already in production today, these systems will be delivered in significant quantity with high-technology European inputs to build and sustain affordable mass for NATO's fighter forces."GA-ASI is the world's foremost builder of unmanned aerial systems, delivering more than 1,200 aircraft over three decades and supporting a net fleet operation approaching 9 million flight hours. The company has pioneered three types of unmanned combat jets, including the groundbreaking MQ-20 Avenger® (2009) and the U.S. Air Force's XQ-67A Off-Board Sensing Station (2024). Its YFQ-42A fighter was rapidly developed from the XQ-67A baseline and is expected to fly only 18 months after its predecessor.International collaboration is a significant focus for General Atomics. GA-ASI aircraft are flown by the US, the U.K., Spain, France, Italy, Netherlands, Japan, India and many other customers around the world. GA-ASI's high-value supply chain for UAS extends deeply into these partner nations, where major airframe components, subsystems, and complete sensor payloads are manufactured.GA-ATS is a German aircraft manufacturing and Maintenance, Repair and Overhaul company. Aircraft have been manufactured and serviced on the company site for more than 40 years. The company conducts MRO on NH-90 helicopters for the German military; builds, sustains, and modifies the Do-228 multi-role aircraft; and performs engine overhaul on the TPE-331-10 turboprop engine, common to both Do-228 and MQ-9A/B unmanned aircraft.A new Collaborative Combat Aircraft for Europe, leveraging the YFQ-42A baseline, will benefit from these previous successes, Blue explained."European nations are essential and irreplaceable allies for the United States and our company," he said. "We will supply a mature aircraft baseline already well along in its development, and we'll look forward to German and other European national partnerships to bring these aircraft online in European and NATO air forces as the Continent grows a new generation of highly capable defense systems."About GA-ASIGeneral Atomics Aeronautical Systems, Inc. is the world's foremost builder of Unmanned Aircraft Systems (UAS). Logging nearly 9 million flight hours, the Predator® line of UAS has flown for over 30 years and includes MQ-9A Reaper®, MQ-1C Gray Eagle®, MQ-20 Avenger®, and MQ-9B SkyGuardian®/SeaGuardian®. The company is dedicated to providing long-endurance, multi-mission solutions that deliver persistent situational awareness and rapid strike.For more information, visit www.ga-asi.com.Avenger, EagleEye, Gray Eagle, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are trademarks of General Atomics Aeronautical Systems, Inc., registered in the United States and/or other countries.Contact InformationGA-ASI Media Relationsasi-mediarelations@ga-asi.com(858) 524-8101SOURCE: General Atomics Aeronautical Systems, Inc. Copyright 2025 ACN Newswire via SeaPRwire.com.

英國費爾福德, 2025年7月18日 - (亞太商訊 via SeaPRwire.com) - 通用原子公司正邁出大膽一步，計劃迅速交付一款歐洲協同作戰飛機（CCA）——該飛機將以一個成熟的美國平台為基礎，在歐洲組裝，並搭載歐洲任務系統——為此，通用原子將其美國與德國的航空航太附屬公司整合為一個聯合運作體系。YFQ-42A這款新型飛機源自美國空軍的 YFQ-42A 原型機，目前正進行地面測試，預計將於今年夏季稍晚首次試飛，由位於加州聖地牙哥的通用原子航空系統公司（General Atomics Aeronautical Systems, Inc.，簡稱 GA-ASI）設計並建造。歐洲的任務系統客製化與在地製造，將由通用原子的德國航空航太子公司——位於慕尼黑附近奧伯法芬霍芬（Oberpfaffenhofen）的通用原子航太科技公司（General Atomics Aerotec Systems GmbH，簡稱 GA-ATS）提供支援。利用這些跨大西洋知名航太企業過去的投資成果，為歐洲無人戰鬥機的開發提供了起步優勢，並開啟了一條能滿足歐洲國家快速採購時程的可行途徑。這也為未來的國際合作及本土防禦夥伴關係建立了一條成熟路徑，基於雙方公司在全球飛機交付方面的成功經驗。「我們非常期待將我們在無人飛行系統方面的專長，與歐洲國防工業在機載感測器與武器系統方面的技術結合，首步即從我們在德國的附屬公司 GA Aerotec Systems GmbH 開始，」通用原子航空系統公司（GA-ASI）執行長林登·布魯（Linden Blue）表示。「我們已具備一款成熟的協同作戰飛機設計，目前正處於量產階段，這些系統將以大量具備高科技歐洲元件的方式交付，用於建立並維持北約戰鬥機部隊所需的可負擔戰力規模。」GA-ASI 是全球領先的無人航空系統製造商，三十年來已交付超過 1,200 架飛機，支援的機隊總飛行時數已接近 900 萬小時。該公司已開發三種無人戰鬥機，包括開創性的 MQ-20「復仇者」（Avenger®，2009 年）以及美國空軍的 XQ-67A 離機感測站（2024 年）。其 YFQ-42A 戰鬥機即是在 XQ-67A 的基礎上迅速研製，預計將在前代首飛後僅 18 個月內完成首飛。國際合作是通用原子公司的重要戰略之一。GA-ASI 的飛機目前由美國、英國、西班牙、法國、義大利、荷蘭、日本、印度及其他多個國家使用。其無人航空系統（UAS）供應鏈深入這些夥伴國家，在當地生產機體主要結構、子系統以及完整的感測器組件。GA-ATS 是一家德國飛機製造與維修、保養、大修（MRO）公司，已有超過 40 年的飛機製造與服務經驗。該公司目前為德國軍方進行 NH-90 直升機的 MRO 任務，並負責 Do-228 多功能飛機的製造、維修與改裝作業，同時進行 TPE-331-10 渦輪螺旋槳引擎的翻修，該型引擎廣泛應用於 Do-228 與 MQ-9A/B 等無人機型。Blue 表示，一款基於 YFQ-42A 平臺開發的歐洲協同作戰飛機，將直接受惠於這些既有的成功經驗。「歐洲各國是美國及我們公司的關鍵且無可取代的盟友，」他說，「我們將提供一款已高度成熟、開發進度領先的飛機作為基礎，並期待與德國及其他歐洲國家的國防夥伴合作，將這些飛機納入歐洲與北約空軍體系中，支持歐洲發展新一代高性能防禦系統。」關於 GA-ASI 通用原子航空系統公司（General Atomics Aeronautical Systems, Inc.，GA-ASI）是全球領先的無人航空系統（UAS）製造商。GA-ASI 的 Predator® 系列無人機已累積超過 800 萬飛行小時，並在過去 30 年內持續服役，旗下機型包括 MQ-9A Reaper®、MQ-1C Gray Eagle® 25M、MQ-20 Avenger® 以及 MQ-9B SkyGuardian®/SeaGuardian®。公司致力於提供長航時、多任務解決方案，以實現持續的態勢感知與快速打擊能力。欲了解更多信息，請訪問 www.ga-asi.com 。Avenger、Grey Eagle、Lynx、Predator、Reaper、SeaGuardian 和 SkyGuardian 是 General Atomics Aeronautical Systems, Inc. 在美國和/或其他國家註冊的商標。聯絡資訊GA-ASI 媒體關係asi-mediarelations@ga-asi.com(858) 524-8101來源: General Atomics Copyright 2025 亞太商訊 via SeaPRwire.com.

香港，2025年7月17日 - (亞太商訊 via SeaPRwire.com) - 香港創新型手術機械人代表企業康諾思騰（Cornerstone Robotics）欣然宣佈，近日已與新加坡國立健保集團（NHG Health）及新加坡南洋理工大學（NTU Singapore）李光前醫學院（LKCMedicine）簽署三方合作備忘錄，旨在共同深化三方在新加坡醫療領域的合作，包括推動機械人輔助手術技術的臨床研究、醫療創新、人才培訓及臨床應用普及的加速發展，構建當地智慧醫療新生態。前排左起：康諾思騰聯合創始人、運營及商業策劃副總裁鄭君樂博士；新加坡國立健保集團首席執行官Joe Sim教授；南洋理工大學李光前醫學院院長沈祖堯教授；後排左起：康諾思騰聯合創始人、首席技術官兼首席運營官王澤睿博士；南洋理工大學副校長（產業）藍欽揚教授；新加坡衛生部長兼社會政策統籌部長王乙康先生；新加坡國立健保集團董事會主席Tan Tee How先生本次合作備忘錄訂明三方的合作將聚焦三大戰略方向 - 機械人輔助手術技術的成本優化與可持續定價體系構建、通過創新研究拓展手術應用場景，及遠程機械人手術技術的開發與培訓體系建設。近年來，通過持續提升手術精準度、優化醫生培訓及技術應用，機械人輔助手術技術已成為現代微創醫療技術的發展基礎，並正在重塑外科手術領域，它融合了先進的影像技術、智能算法與精密器械控制技術，有助於提升手術效果的穩定性、減少手術帶來的組織損傷，幫助患者縮短康復週期。作為該領域的引領者，由康諾思騰完全自主研發的旗艦產品Sentire思騰®腔鏡手術機械人（C1000）目前已在香港及中國內地完成臨床試驗，並已獲得中國國家藥品監督管理局（NMPA）之認證上市。繼與香港中文大學醫學院合作後，是次合作備忘錄標誌著康諾思騰在推動手術機械人技術應用與普及的戰略上邁出了關鍵一步。康諾思騰創始人兼首席執行官歐國威教授表示：「我們對能與NHG Health及LKCMedicine攜手共同推動新加坡機械人輔助手術技術發展深感榮幸。我們將一如既往致力於融合精密工程、智能演算法及臨床需求，推動先進手術機械人技術惠及全球病患。是次合作將加快機械人輔助手術技術於新加坡的應用普及，進一步推動高質素外科醫療服務的全球化發展。」展望未來，合作三方將持續深化合作，協同推動技術創新、提升臨床價值及培育外科人才，於新加坡乃至全球範圍攜手構建更智能、更普惠的外科醫療新生態。關於康諾思騰（Cornerstone Robotics）康諾思騰（Cornerstone Robotics）是香港本地創新型手術機械人的引領者，懷著「引領醫療創新，心繫天下健康」的願景，致力於打造安全高效的手術機械人平台，提升香港乃至全球範圍優質醫療資源的可及性，讓更多患者受益於高端醫療科技帶來的高品質醫療服務。公司已在全球設立四大研發中心，並在中國香港、深圳、北京、上海和美國波士頓、荷蘭阿姆斯特丹、英國樸次茅斯設有分支機構，在粵港澳大灣區建成超萬平米的量產工廠。憑藉雄厚的技術實力，公司已成功突破技術難題，搭建全面底層技術平台，由康諾思騰自主研發的Sentire思騰®腔鏡手術機械人已完成多個重要專科的臨床試驗，並正式獲得中國國家藥品監督管理局（NMPA）批准上市，同步在全球範圍申請醫療器械認證，服務全球醫護，惠及更多病患。如欲瞭解更多，可瀏覽：https://en.csrbtx.com/關於新加坡國立健保集團（NHG Health）新加坡國立健保集團（NHG Health） 是新加坡領先的公立醫療服務機構，以卓越的臨床診療質量及全生命週期健康管理理念享譽業界。集團構建覆蓋基礎醫療、急症醫院及國家級專科中心的戰略級醫療網絡，旗下涵蓋：陳篤生醫院、邱德拔醫院、兀蘭健康園區、義順社區醫院、國立健保綜合診療所、心理衛生學院、全國皮膚中心及國家傳染病中心。依託跨領域協作生態，集團攜手學術與產業夥伴共推新加坡本土的醫學教育革新、臨床研究突破與健康解決方案創新，精准響應國民健康需求。作為新加坡中北部區域健康總規劃機構，國立健保集團深度聯動基層診所及社康服務組織，全方位守護社區居民的身心健康與社會福祉。國立健保集團矢志構建強韌的健康共同體，將持續增益民眾健康水準，共築全民健康福祉。如欲瞭解更多，可瀏覽：www.nhghealth.com.sg關於新加坡南洋理工大學（NTU Singapore）新加坡南洋理工大學（NTU Singapore）是一所科研型公立大學，設有本科商學院、計算與數據科學學院、工程學院、人文藝術與社會科學學院、李光前醫學院、理學院及相應的研究生院，辦學規模達35,000人。學校亦擁有多個世界級自治研究院 - 包括國立教育學院、拉惹勒南國際研究院、新加坡環境生命科學工程中心，以及地球觀測站、南洋環境與水資源研究院、能源研究院（ERI@N）等頂尖科研中心。在「智慧校園」願景驅動下，南洋理工大學積極融合數字技術及智能解決方案，持續優化教學與校內生活環境，推動前沿知識探索及資源可持續發展。學校常年位列全球頂尖學府，主校區屢獲評「全球最美校園」。 學校在可持續發展領域亦成就斐然，其所有符合認證標準的建築項目全數斬獲新加坡建設局頒發的綠色建築標誌最高等級 - 白金認證。除主校區外，大學亦前瞻性佈局醫療領域，於新加坡核心醫療區諾維娜設立醫學院專屬校區。如欲瞭解更多，可瀏覽：www.ntu.edu.sg Copyright 2025 亞太商訊 via SeaPRwire.com.